Agnieszka Hobbs

WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed

S. Gamblin, R. Beale, S. Kjaer, 2022, The Lancet.

Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults

S. Evans, V. Libri, J. Nicod, 2023, bioRxiv.

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

V. Libri, R. Gilson, S. Gamblin, 2023, The Lancet. Infectious diseases.

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein

S. Burns, D. Lowe, Vinit Upasani, 2023, Clinical Infectious Diseases.

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

T. Russell, J. Hellewell, Scott Warchal, 2024, The Lancet. Infectious diseases.